YothersG., O'ConnellM.J., AllegraC.J.Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses.J Clin Oncol2011; 29: 3768–74.
2.
NordlingerB., SorbyeH., GlimeliusB.Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.Lancet2008; 371: 1007–16.
3.
ImaiK., AllardM.A., BenitezC.C.Early recurrence after hepatectomy for colorectal liver metastases: what optimal definition and what predictive factors?Oncologist2016; 21: 887–94.
4.
ValleJ. W., PalmerD., JacksonR.Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study.J Clin Oncol2014; 32: 504–12.
